Cargando…
Cost–benefit of limited isolation and testing in COVID-19 mitigation
The international community has been put in an unprecedented situation by the COVID-19 pandemic. Creating models to describe and quantify alternative mitigation strategies becomes increasingly urgent. In this study, we propose an agent-based model of disease transmission in a society divided into cl...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596701/ https://www.ncbi.nlm.nih.gov/pubmed/33122753 http://dx.doi.org/10.1038/s41598-020-75640-2 |
_version_ | 1783602169290686464 |
---|---|
author | Eilersen, Andreas Sneppen, Kim |
author_facet | Eilersen, Andreas Sneppen, Kim |
author_sort | Eilersen, Andreas |
collection | PubMed |
description | The international community has been put in an unprecedented situation by the COVID-19 pandemic. Creating models to describe and quantify alternative mitigation strategies becomes increasingly urgent. In this study, we propose an agent-based model of disease transmission in a society divided into closely connected families, workplaces, and social groups. This allows us to discuss mitigation strategies, including targeted quarantine measures. We find that workplace and more diffuse social contacts are roughly equally important to disease spread, and that an effective lockdown must target both. We examine the cost–benefit of replacing a lockdown with tracing and quarantining contacts of the infected. Quarantine can contribute substantially to mitigation, even if it has short duration and is done within households. When reopening society, testing and quarantining is a strategy that is much cheaper in terms of lost workdays than a long lockdown. A targeted quarantine strategy is quite efficient with only 5 days of quarantine, and its effect increases when testing is more widespread. |
format | Online Article Text |
id | pubmed-7596701 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-75967012020-11-03 Cost–benefit of limited isolation and testing in COVID-19 mitigation Eilersen, Andreas Sneppen, Kim Sci Rep Article The international community has been put in an unprecedented situation by the COVID-19 pandemic. Creating models to describe and quantify alternative mitigation strategies becomes increasingly urgent. In this study, we propose an agent-based model of disease transmission in a society divided into closely connected families, workplaces, and social groups. This allows us to discuss mitigation strategies, including targeted quarantine measures. We find that workplace and more diffuse social contacts are roughly equally important to disease spread, and that an effective lockdown must target both. We examine the cost–benefit of replacing a lockdown with tracing and quarantining contacts of the infected. Quarantine can contribute substantially to mitigation, even if it has short duration and is done within households. When reopening society, testing and quarantining is a strategy that is much cheaper in terms of lost workdays than a long lockdown. A targeted quarantine strategy is quite efficient with only 5 days of quarantine, and its effect increases when testing is more widespread. Nature Publishing Group UK 2020-10-29 /pmc/articles/PMC7596701/ /pubmed/33122753 http://dx.doi.org/10.1038/s41598-020-75640-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Eilersen, Andreas Sneppen, Kim Cost–benefit of limited isolation and testing in COVID-19 mitigation |
title | Cost–benefit of limited isolation and testing in COVID-19 mitigation |
title_full | Cost–benefit of limited isolation and testing in COVID-19 mitigation |
title_fullStr | Cost–benefit of limited isolation and testing in COVID-19 mitigation |
title_full_unstemmed | Cost–benefit of limited isolation and testing in COVID-19 mitigation |
title_short | Cost–benefit of limited isolation and testing in COVID-19 mitigation |
title_sort | cost–benefit of limited isolation and testing in covid-19 mitigation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596701/ https://www.ncbi.nlm.nih.gov/pubmed/33122753 http://dx.doi.org/10.1038/s41598-020-75640-2 |
work_keys_str_mv | AT eilersenandreas costbenefitoflimitedisolationandtestingincovid19mitigation AT sneppenkim costbenefitoflimitedisolationandtestingincovid19mitigation |